USP22 and breast cancer: USP22, acting as a deubiquitinating enzyme, inhibits the degradation of FOXM1 in breast cancer, thereby upregulating the transcription of ITGB1 and supporting the self-renewal of breast cancer stem cells (K. Liu et al., 2023).